Digital Cohort of Rheumatic Disease

Adherence to self-monitoring in rheumatic disease: a prospective cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21144

Enrollment

186

Registered

2020-02-28

Start date

2020-02-28

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing Spondylithis, Psoriatic Arthritis, Rheumatoid Arthritis

Interventions

At inclusion patients are asked to use the MijnReuma Reade smartphone application. The app provides the possibility to complete a weekly questionnaire. This questionnaire has been derived from the MDH

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with Ankylosing Spondylithis/Psoriatic Arthritis/ Rheumatoid Arthritis 2. Able to speak and write Dutch 3. Owning a Andriod or IOs smartphone

Exclusion criteria

Exclusion criteria: Taking part in an other digital self-monitoring trial

Design outcomes

Primary

Measure	Time frame
Adherence at 3 months	—

Secondary

Measure	Time frame
Adherence at 6 months, patient empowerment as measured by the Effective Consumer scale (EC-17), patient-physician interaction as measured by the Perceived Efficacy in Patient-Physician Interaction Questionnaire (PEPPI-5)	—

Contacts

Public ContactJim Wiegel

Reade Reumatologie

j.wiegel@reade.nl020-2421805

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)